One of the most striking themes to emerge from the Lindsay Clancy murder trial isn’t that she failed to seek mental health care. It’s that she sought it repeatedly.
In the months before her three children died in January 2023, Clancy saw multiple mental health professionals, visited emergency departments, participated in psychiatric programs and underwent frequent medication changes. As the trial has unfolded, the focus has shifted from a simple question of whether she received treatment to a more complicated one: how well that treatment was coordinated.
That distinction has become one of the most significant issues in the courtroom.
A rapidly changing course of treatment
According to testimony and records presented during trial, Clancy received approximately 30 prescriptions involving 13 psychiatric medications between September 2022 and January 2023. The medications included antidepressants, antipsychotics, benzodiazepines, mood stabilizers and sleep medications as clinicians attempted to relieve worsening symptoms that included depression, insomnia, anxiety and intrusive thoughts.
The number of prescriptions alone does not establish that her care was inappropriate. Instead, it has become a central part of the defense’s argument that Clancy’s mental health was deteriorating despite intensive treatment and repeated adjustments to her medications. Prosecutors, meanwhile, argue that her treatment records do not support the defense’s claim that she was suffering from postpartum psychosis when the killings occurred.
What the trial has revealed about coordination
Perhaps the most significant testimony has concerned communication among Clancy’s healthcare providers.
Psychiatric nurse practitioner Rebecca Jollotta acknowledged during testimony that she did not have complete information from Clancy’s other treating clinicians and did not consult with another psychiatrist or hospitals involved in her care. Therapist Latiesha Dukes similarly testified that she had not reviewed Jollotta’s treatment notes documenting increasingly serious symptoms before continuing her own treatment of Clancy.
Those admissions have become an important part of the defense’s broader argument that no single provider had a complete picture of Clancy’s condition as she moved among different clinicians and treatment settings.
Jurors have also heard testimony that one psychiatric nurse practitioner considered whether bipolar disorder or a mixed manic state could explain Clancy’s symptoms, while Patrick Clancy testified that he rejected that possibility at the time. Additional testimony described concerns raised during treatment about medication management and the appropriate level of psychiatric care.
Whether those communication gaps affected Clancy’s care remains a disputed issue. Clancy and her former husband have filed separate civil lawsuits alleging failures by members of her medical team, while the healthcare providers deny negligence. Those civil claims have not been resolved.
A broader challenge in maternal mental health
The issues highlighted during the trial extend beyond one patient.
Maternal mental health disorders are estimated to affect about one in five women in the United States, making them one of the most common complications associated with pregnancy and childbirth. Research also suggests that approximately one-third of maternal depressive episodes begin during pregnancy, while about 40% begin after delivery. Women with an established bipolar disorder face an especially elevated risk of mood episodes during the perinatal period.
Researchers have long identified fragmented care as one of the obstacles to effective treatment. Patients may receive care from obstetric providers, primary care physicians, psychiatrists, therapists and emergency departments, each operating within separate healthcare systems or electronic medical records.
National quality-measure data continue to show significant gaps in maternal mental health screening, while other studies estimate that many maternal mental health conditions go undiagnosed and that a large share of women who are diagnosed still do not receive treatment. Access is especially limited in communities with shortages of clinicians specializing in perinatal mental health.
Policymakers are responding
Several states have expanded efforts to improve maternal mental healthcare in recent years.
Virginia enacted legislation in 2026 requiring many health insurance plans to cover maternal mental health screenings during pregnancy and after childbirth. Massachusetts has also expanded maternal health initiatives, including broader access to midwives, doulas, postpartum support services and maternal mental health screening.
Supporters of these reforms argue that improving coordination among providers and identifying patients earlier could strengthen care. Whether such changes would have altered the outcome in Clancy’s case is impossible to know and is not a question the jury has been asked to answer.
What the trial can, and cannot, tell us
The Clancy trial has provided an unusually detailed look at how one patient moved through a complex mental healthcare system over several months.
It has also revealed documented communication gaps between some of the clinicians involved in her care. Those facts are now part of the trial record.
What the evidence does not establish is whether those gaps caused the tragedy or whether different coordination would have prevented it. Those questions remain the subject of competing arguments by the defense, the prosecution and separate civil litigation.
Whatever the jury ultimately decides about Clancy’s criminal responsibility, the case has already renewed attention on broader questions about maternal mental health, continuity of care and how healthcare systems manage patients whose conditions can change rapidly over a short period.